Status:
COMPLETED
Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers
Lead Sponsor:
JW Pharmaceutical
Conditions:
Healthy
Eligibility:
All Genders
19-55 years
Phase:
PHASE1
Brief Summary
This study is conducted to evaluate the safety/tolerability and PK/PD of JW1601 after oral administration in healthy Korean, Caucasian and Japanese adult volunteers
Detailed Description
This is a dose block-randomized, double-blind, placebo-controlled, single and multiple ascending dose study to assess the safety, tolerability and PK/PD profile by administering investigational produc...
Eligibility Criteria
Inclusion
- \- Subjects who have voluntarily given written informed consent to participate in the study and comply with all study requirements after getting detailed explanation and full understanding of the study
Exclusion
- \- Subjects judged by the investigators unsuitable for participating in the study based on any other reasons
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT04018170
Start Date
February 15 2019
End Date
December 15 2019
Last Update
February 13 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital
Seoul, South Korea, 06725
2
Seoul National University Hospital
Seoul, South Korea